Molina Healthcare (MOH)
(Delayed Data from NYSE)
$306.00 USD
-3.30 (-1.07%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $306.03 +0.03 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$306.00 USD
-3.30 (-1.07%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $306.03 +0.03 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Zacks News
What's in Store for Molina Healthcare (MOH) Q3 Earnings?
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results are likely to be affected by soft revenues, partly offset by improved marketplace business.
HCA Healthcare (HCA) to Post Q3 Earnings: What to Expect
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results are likely to reflect elevated expenses, partly offset by higher topline from increase in admissions and licensed beds.
Anthem's (ANTM) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) third-quarter earnings gain from increased revenues.
Centene's (CNC) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Centene's (CNC) third-quarter earnings gain traction from higher revenues.
What to Expect for Universal Health's (UHS) Q3 Earnings
by Zacks Equity Research
Universal Health (UHS) is likely to have benefited from strong segmental performances at Acute Care and Behavioral Health in Q3, partly offset by high costs.
Anthem (ANTM) Gears Up for Q3 Earnings: What's in Store?
by Zacks Equity Research
Anthem (ANTM) is likely to have gained from solid revenues in the third quarter.
Nokia (NOK) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Solid progress in its expansion areas of Software and Enterprise and excellent momentum in IP Routing business are likely to have benefited Nokia's (NOK) third-quarter 2019 financial results.
Molina Healthcare Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Molina Healthcare has been struggling lately, but the selling pressure may be coming to an end soon.
What's in the Cards for Centene's (CNC) Earnings in Q3?
by Zacks Equity Research
Centene's (CNC) third-quarter earnings are likely to have grown on the back of solid revenues.
UnitedHealth Group (UNH) in Focus: Stock Moves 8.2% Higher
by Zacks Equity Research
UnitedHealth Group (UNH) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Why Molina (MOH) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
UnitedHealth (UNH) Q3 Earnings and Revenues Beat, Guidance Up
by Sapna Bagaria
UnitedHealth's (UNH) higher revenues, strength in both segments -- UnitedHealthcare and Optum -- plus membership growth leads to earnings outperformance.
Humana to Provide Florida's Retirees With Medicare Plans
by Zacks Equity Research
Humana's (HUM) Medicare plans to help the State of Florida Medicare-eligible retirees and their eligible dependents achieve better health outcomes.
MEDNAX (MD) to Sell MedData for Focusing on Core Business
by Zacks Equity Research
MEDNAX (MD) to divest its billing services business for streamlining its operations.
Is Molina (MOH) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will UnitedHealth's (UNH) Benefits Business Aid Q3 Earnings?
by Zacks Equity Research
Strength in UnitedHealth's (UNH) health service segment is likely to reflect in Q3 results.
The Zacks Analyst Blog Highlights: KB Home, Beazer, American Electric and Molina
by Zacks Equity Research
The Zacks Analyst Blog Highlights: KB Home, Beazer, American Electric and Molina
Humana's New Plans to Complement VA Healthcare Coverage
by Zacks Equity Research
Humana's (HUM) Humana Honor Medicare Advantage plans to help veterans get better health outcomes. It will also complement the VA plan.
4 Stocks to Win Big as Powell Hints at Another Rate Cut
by Tirthankar Chakraborty
Fed Chair Powell leaves the door open for another rate cut in October as jobs growth last month was not as robust as expected and trade concerns continue to impede economic growth.
Centene's Carolina Complete Health Wins Medicaid Contract
by Zacks Equity Research
Centene's (CNC) provider-led North Carolina subsidiary clinches Medicaid contract to provide services in additional areas.
Humana's (HUM) Medicare Business Aids, High Costs Persist
by Zacks Equity Research
Humana's (HUM) revenues and membership gain on strong Medicare business. However, high expenses hurt.
Economic Worries Buoy Rate-Cut Hopes: 5 Winners
by Tirthankar Chakraborty
Worries about a probable economic downturn have increased this week, fueling rate-cut hopes. CME's Fedwatch indicator showed that almost 90.3% of investors are now expecting another rate cut.
Tenet Healthcare's Strategic Initiatives Aid, Revenues Drag
by Zacks Equity Research
Strategic divestitures bode well for Tenet Healthcare's (THC) growth. However, depleting revenues is a lingering woe.
Molina (MOH) Stock Moves -0.22%: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $109.48, marking a -0.22% move from the previous day.